New HIV combo pill tested in kids and teens
NCT ID NCT02881320
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 30 times
Summary
This study tests a three-in-one pill (Bictegravir/Emtricitabine/Tenofovir Alafenamide) for HIV-1 in children and teens aged 2 to 17. The goal is to see how the body processes the drug, confirm the right dose, and check safety. Participants take the pill once daily, and researchers monitor virus levels and side effects for up to 48 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor College of Medicine Children's Foundation - Uganda
Kampala, Uganda
-
Be Part Ypluntu Centre
Cape Town, 7646, South Africa
-
Bellevue Hospital
New York, New York, 10016, United States
-
Children's National Health System
Washington D.C., District of Columbia, 20010, United States
-
Department of Paediatrics and Child Health
Bloemfontein, 9301, South Africa
-
Dr. J Fourie Medical Centre
Dundee, 3000, South Africa
-
Duke Children's Health Center, Pediatric Infectious Diseases
Durham, North Carolina, 27710, United States
-
Empilweni Service and Research Unit (ESRU)
Johannesburg, 2112, South Africa
-
Enhancing Care Foundation, Durban International Clinical Research Site
Durban, 4302, South Africa
-
FAMCRU, Ward J8
CapeTown, 7505, South Africa
-
Faculty of Medicine Siriraj Hospital, Mahidol University
Bangkok, 10700, Thailand
-
Faculty of Medicine, Khon Kaen University
Khon Kaen, 40002, Thailand
-
Grady Health System Ponce Center Family and Youth Clinic
Atlanta, Georgia, 30322, United States
-
Joint Clinical Research Centre
Kampala, 10005, Uganda
-
Makerere University, Johns Hopkins (MU-JHU) Research Collaboration
Kampala, 0000, Uganda
-
Midway Immunology and Research Center
Ft. Pierce, Florida, 34982, United States
-
Perinatal HIV Research Unit
Soweto, 2013, South Africa
-
St. Christopher's Hospital for Children/Section of Immunology
Philadelphia, Pennsylvania, 19134, United States
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
-
The HIV Netherlands Australia Thailand Research Collaboration
Bangkok, 10330, Thailand
-
USF Clinic at Children's Medical Services (study visits and drug storage)
Tampa, Florida, 33606, United States
-
University of Florida Health
Gainesville, Florida, 32209, United States
-
VX Pharma(Pty) Ltd
Pretoria, 0087, South Africa
-
Wayne Pediatric Clinic
Detroit, Michigan, 48201, United States
-
Wits RHI Shandukani Research Centre, Wits Reproductive Health & HIV Institute
Johannesburg, 2038, South Africa
Conditions
Explore the condition pages connected to this study.